Shopping Cart
- Remove All
- Your shopping cart is currently empty
Elisidepsin (PM02734), a cyclic depsipeptide, exhibits antineoplastic activity by inhibiting cancer cell proliferation and is under research for the treatment of various cancers, including non-small cell lung cancer (NSCLC) [1] [2] [3] [4].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | Elisidepsin (PM02734), a cyclic depsipeptide, exhibits antineoplastic activity by inhibiting cancer cell proliferation and is under research for the treatment of various cancers, including non-small cell lung cancer (NSCLC) [1] [2] [3] [4]. |
In vitro | Elisidepsin, administered over 72 hours, suppresses the proliferation of diverse cancer cell types, demonstrating half-maximal inhibitory concentration (IC50) values starting from 0. |
In vivo | Elisidepsin administered intravenously at a dose of 100 µg/kg demonstrates efficacy in inhibiting lung cancer xenografts [3]. |
Alias | PM02734 |
Molecular Weight | 1477.87 |
Formula | C75H124N14O16 |
Cas No. | 681272-30-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.